当前位置: X-MOL 学术ACS Pharmacol. Transl. Sci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2
ACS Pharmacology & Translational Science Pub Date : 2020-11-10 , DOI: 10.1021/acsptsci.0c00163
Ke Liu 1 , Rongfeng Zou 1 , Wenqiang Cui 1, 2 , Meiqing Li 1, 2 , Xueying Wang 1 , Junlin Dong 1 , Hongchun Li 1 , Hongpei Li 3 , Peihui Wang 4 , Ximing Shao 1 , Wu Su 1 , H C Stephen Chan 1 , Hongchang Li 1 , Shuguang Yuan 1
Affiliation  

The outbreak of COVID-19 by the end of 2019 has posed serious health threats to humanity and jeopardized the global economy. However, no effective drugs are available to treat COVID-19 currently and there is a great demand to fight against it. Here, we combined computational screening and an efficient cellular pseudotyped virus system, confirming that clinical HDAC inhibitors can efficiently prevent SARS-CoV-2 and potentially be used to fight against COVID-19.

中文翻译:

临床 HDAC 抑制剂是防止 SARS-CoV2 进入的有效药物

到 2019 年底,COVID-19 的爆发对人类健康构成了严重威胁,并危及全球经济。然而,目前没有有效的药物可以治疗 COVID-19,对抗它的需求很大。在这里,我们结合计算筛选和有效的细胞假型病毒系统,证实临床 HDAC 抑制剂可以有效预防 SARS-CoV-2,并有可能用于对抗 COVID-19。
更新日期:2020-12-12
down
wechat
bug